Chemical Structure Of Sildenafil Citrate (Image 1)
Sildenafil Tablet, Film Coated
Product Images NDC 71205-267
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 71205-267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
71205-267-30 (Image 10)
This is a medication labeled as Siidenafil 50mg, which is also known as Sildenafil 50mg. It comes in a package of 30 tablets per bottle with a drug identification number (DIN) of 71205-267-30. The tablets are white to off-white in color, film-coated, modified oval-shaped, convex, and are embossed with "TEVA" on one side and "5342" on the other. It is manufactured by Pliva Hrvatska in Zagreb, Croatia, and has been relabeled by Proficient Rx LP in Thousand Oaks, CA. The lot number is 00000, and it is recommended to store the medication at 20°C to 25°C.*
Figure1 (Image 2)
Figure2 (Image 3)
This appears to be a graph or chart showing the change in SBP (systolic blood pressure) measured in mmHg over time postdose (in hours). The graph shows two groups: one taking Doxazosin with a placebo and the other taking Doxazosin with Sildenafil 25mg. However, without the actual graph or chart, it is difficult to provide a comprehensive description.*
Figure3 (Image 4)
This text appears to be a table or graph showing the change in systolic blood pressure (SBP) in millimeters of mercury (mmHg) for two groups of participants. The first group received doxazosin and a placebo, while the second group received doxazosin and 50 milligrams of sildenafil. The text also includes a section labeled "Time Postdose (1)."*
Figure4 (Image 5)
Figure5 (Image 6)
Figure6 (Image 7)
Figure7 (Image 8)
This is a chart indicating the percentage of patients reporting improvement in different treatment groups. The different groups are placebo, 25mg, 50mg, and 100mg of Sildenafil. The percentage of improvement ranged from 82% in the 100mg group to 3% in the placebo group. The overall treatment was found to have a significant impact based on a p-value of less than 0.0001.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
